Delivery Order SPE2DB22D2206-SPE2DB23FGZ65
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,227.28 contract is for the delivery of Fluorometholone 0.1% Eye Drops, a 10 ml ophthalmic medication. The contract has a firm fixed price and runs through November 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fluorometholone 0.1% eye drops. The $3,842.10 firm fixed-price delivery order falls under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,808.80, is for the delivery of Fluorometholone 0.1% eye drops in 10 milliliter bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of November 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,532.96, is for the delivery of Fluorometholone 0.1% eye drops, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of January 30, 2025. AmerisourceBergen holds significant Indefinite Delivery Contracts...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $5,407.10 delivery order for fluorometholone 0.1% eye drops. The contract, awarded by the Defense Logistics Agency (DLA), is a firm fixed-price delivery order with a completion date of September 13, 2023. The award is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,244.37 firm fixed-price delivery order is for the supply of Fluorometholone 0.1% eye drops, a medication used to treat various eye conditions. The contract has an ultimate completion date of August 5, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to provide pharmaceutical and medical supplies to...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $25,844.84 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order, which does not have a set-aside designation, is for the supply of Fluorometholone 0.1% eye drops with an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,132.34, is a Firm Fixed Price Delivery Order for the supply of FLUOROMETHOLONE 0.1% EYE DROP 5ML. The contract has an ultimate completion date of December 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluorometholone 0.1% eye drops, a prescription medication, with a ceiling value of $2,225.50 and a period of performance through April 2025. The contract is a delivery order, with a firm fixed price pricing type, and does not have a set-aside designation, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The $10,837.55 firm fixed price delivery order is for the supply of Fluorometholone 0.1% eye drops, a specialty brand name pharmaceutical product. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FGZ65Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of Fluorometholone 0.1% eye drops, a pharmaceutical product, with a ceiling value of $1,202.96 and an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs demonstrate the company's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 5/2/23 |